Skip to main content
. Author manuscript; available in PMC: 2012 Oct 15.
Published in final edited form as: Clin Cancer Res. 2009 Nov 24;15(23):7441–7446. doi: 10.1158/1078-0432.CCR-09-1361

Figure 2.

Figure 2

Systemic TM therapy remodels mammary gland ductal morphogenesis in Her2/neu transgenic and FVB mice. A, mammary gland ductal network. Mammary glands from control and TM-treated Her2/neu and FVB mice were isolated and processed for whole mount analysis using carmine-red staining. The complexity of mammary ductal branching was quantified using carmine-red stained mammary glands to count the number of secondary branches in three representative fields (100X). Mean number of secondary branches per field was calculated and presented as mean ± SEM. *, p-value <0.05. B, mammary gland histology. Mammary glands from control and TM-treated Her2/neu and FVB mice were isolated, fixed, and processed for hematoxylin and eosin staining. Mean number of mammary epithelial cells per field (100X) was calculated and presented as mean ± SEM.